Cargando…

Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases

Detalles Bibliográficos
Autor principal:	Zhou, Honghui
Lenguaje:	eng
Publicado:	Wiley 2019
Materias:	XX
Acceso en línea:	http://cds.cern.ch/record/2731776

Ejemplares similares

Utilization of physiologically‐based pharmacokinetic model to assess disease‐mediated therapeutic protein‐disease‐drug interaction in immune‐mediated inflammatory diseases
por: Wang, Lujing, et al.
Publicado: (2021)

QUANTITATIVE METHODS IN HUMAN PHARMACOLOGY AND THERAPEUTICS
Publicado: (1959)

Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology
por: Peskov, Kirill, et al.
Publicado: (2019)

A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins
por: Kierzek, Andrzej M., et al.
Publicado: (2019)

Mechanistic Quantitative Pharmacology Strategies for the Early Clinical Development of Bispecific Antibodies in Oncology
por: Betts, Alison, et al.
Publicado: (2020)

AAPS Workshop Report: Strategies to Address Therapeutic Protein–Drug Interactions during Clinical Development
por: Girish, Sandhya, et al.
Publicado: (2011)

Finding Alphas: A Quantitative Approach to Building Trading Strategies
por: Tulchinsky, Igor
Publicado: (2015)

Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases
por: Kim, Seung Hyun, et al.
Publicado: (2018)

Quantitative Methods for Traditional Chinese Medicine Development
por: Chow, Shein-Chung
Publicado: (2015)

Combined Pharmacologic/Nonpharmacologic Intervention in Individuals at High Risk of Developing Type 2 Diabetes: Pro pharmacologic therapy
por: Garber, Alan J.
Publicado: (2009)

Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
por: Zhao, Jing Hua, et al.
Publicado: (2023)

A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation
por: Kim, Seung Hyun, et al.
Publicado: (2019)

Development of individual fitness score for conformity of prescriptions to the “Guidelines For Pharmacological Therapy of Schizophrenia”
por: Inada, Ken, et al.
Publicado: (2022)

Immune-mediated inflammatory disease therapeutics: past, present and future
por: McInnes, Iain B., et al.
Publicado: (2021)

Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy
por: Mi, Ze, et al.
Publicado: (2019)

A Quantitative and Narrative Evaluation of Goodman and Gilman’s Pharmacological Basis of Therapeutics
por: Piper, Brian J., et al.
Publicado: (2019)

Development of pharmacological strategies for mitochondrial disorders
por: Kanabus, M, et al.
Publicado: (2014)

Virtual laboratory strategies for development
por: Canessa, E, et al.
Publicado: (2001)

Developing A Leadership Strategy
por: Neal, Annmarie
Publicado: (2012)

The promises of quantitative systems pharmacology modelling for drug development
por: Knight-Schrijver, V.R., et al.
Publicado: (2016)

Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases
por: Jiang, Yan, et al.
Publicado: (2021)

Quantitative system pharmacology as a legitimate approach to examine extrapolation strategies used to support pediatric drug development
por: Azer, Karim, et al.
Publicado: (2022)

The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies
por: Pressly, Michelle A., et al.
Publicado: (2023)

Potential therapeutic and pharmacological strategies for SARS-CoV2
por: Ghareeb, Doaa A., et al.
Publicado: (2021)

How to Develop a Strategy for Execution
por: Sull, Donald
Publicado: (2018)

The Future of Osteoarthritis Therapeutics: Targeted Pharmacological Therapy
por: Mobasheri, A.
Publicado: (2013)

Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity
por: Fu, Yu, et al.
Publicado: (2020)

Individualized immunoglobulin therapy in chronic immune‐mediated peripheral neuropathies*
por: Allen, Jeffrey A., et al.
Publicado: (2018)

Current developments in pharmacological therapeutics for chronic constipation
por: Jiang, Chunhuan, et al.
Publicado: (2015)

Advances in pharmacological strategies for the prevention of cataract development
por: Gupta, S K, et al.
Publicado: (2009)

Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
por: Zhao, Jing Hua, et al.
Publicado: (2023)

Special issue of clinical pharmacology: advances and applications in new protein therapeutics modulating tumor immunity
por: Frankel, Arthur E
Publicado: (2013)

Investment Strategy for Product Development in the Aerospace Industry
por: Tillman, Frank
Publicado: (2012)

How to Develop a Great Digital Strategy
por: Ross, Jeanne
Publicado: (2016)

Gaseous Mediators as a Key Molecular Targets for the Development of Gastrointestinal-Safe Anti-Inflammatory Pharmacology
por: Danielak, Aleksandra, et al.
Publicado: (2021)

Developing Practical Therapeutic Strategies that Target Protein SUMOylation
por: Cox, Olivia F., et al.
Publicado: (2019)

Developing Emotional and Social Intelligence: Exercises for Leaders, Individuals, and Teams
por: Hughes, Marcia
Publicado: (2010)

Mechanical and pharmacological strategies to reduce the systemic inflammatory response during CABG
por: Tassani, et al.
Publicado: (1999)

A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 2 – Application to Current Therapies in Crohn’s Disease
por: Rogers, Katharine V., et al.
Publicado: (2020)

Cellular Signal Transduction in Toxicology and Pharmacology
por: Boyd, Jonathan
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9asps1o4d9hd8c8heh1h6ggcd6